Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study

Am J Pediatr Hematol Oncol. 1993 Nov;15(4):406-9.

Abstract

Purpose: Six children who had mature or immature sacrococcygeal teratomas diagnosed in the newborn period have since been registered on a Pediatric Oncology Group/Children's Cancer Group germ cell study with recurrent malignant neoplasia [pure yolk sac tumor (YST) or teratoma with yolk sac elements].

Results: Four of the children have responded to therapy, one has died, and one has been lost to follow-up. Review of the slides from five of the original tumors identified microscopic foci of YST in four.

Conclusions: Detection of such foci in neonatal tumors is important because serum alpha-fetoprotein concentrations may not be helpful since they may normally be high in the newborn period due to fetal production.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / pathology*
  • Endodermal Sinus Tumor / drug therapy
  • Endodermal Sinus Tumor / pathology*
  • Endodermal Sinus Tumor / surgery
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery
  • Recurrence
  • Teratoma / drug therapy
  • Teratoma / pathology*
  • Teratoma / surgery
  • Testicular Neoplasms / drug therapy
  • Testicular Neoplasms / pathology*
  • Testicular Neoplasms / surgery
  • alpha-Fetoproteins / analysis

Substances

  • alpha-Fetoproteins